High dose proton and photon-based radiation therapy for 213 liver lesions: a multi-institutional dosimetric comparison with a clinical perspective
- PMID: 38345714
- PMCID: PMC10942931
- DOI: 10.1007/s11547-024-01788-w
High dose proton and photon-based radiation therapy for 213 liver lesions: a multi-institutional dosimetric comparison with a clinical perspective
Abstract
Background: Stereotactic radiotherapy (SRT) and Proton therapy (PT) are both options in the management of liver lesions. Limited clinical-dosimetric comparison are available. Moreover, dose-constraint routinely used in liver PT and SRT considers only the liver spared, while optimization strategies to limit the liver damaged are poorly reported.
Methods: Primary endpoint was to assess and compare liver sparing of four contemporary RT techniques. Secondary endpoints were freedom from local recurrence (FFLR), overall survival (OS), acute and late toxicity. We hypothesize that Focal Liver Reaction (FLR) is determined by a similar biologic dose. FLR was delineated on follow-up MRI. Mean C.I. was computed for all the schedules used. A so-called Fall-off Volume (FOV) was defined as the area of healthy liver (liver-PTV) receiving more than the isotoxic dose. Fall-off Volume Ratio (FOVR) was defined as ratio between FOV and PTV.
Results: 213 lesions were identified. Mean best fitting isodose (isotoxic doses) for FLR were 18Gy, 21.5 Gy and 28.5 Gy for 3, 5 and 15 fractions. Among photons, an advantage in terms of healthy liver sparing was found for Vmat FFF with 5mm jaws (p = 0.013) and Cyberknife (p = 0.03). FOV and FOVR resulted lower for PT (p < 0.001). Three years FFLR resulted 83%. Classic Radiation induced liver disease (RILD, any grade) affected 2 patients.
Conclusions: Cyberknife and V-MAT FFF with 5mm jaws spare more liver than V-MAT FF with 10 mm jaws. PT spare more liver compared to photons. FOV and FOVR allows a quantitative analysis of healthy tissue sparing performance showing also the quality of plan in terms of dose fall-off.
Keywords: Cholangiocarcinoma; HCC; Liver metastasis; Proton therapy; SBRT; SRT.
© 2024. The Author(s).
Conflict of interest statement
None.
Figures



Similar articles
-
Improvement of conformal arc plans by using deformable margin delineation method for stereotactic lung radiotherapy.J Appl Clin Med Phys. 2018 Jan;19(1):184-193. doi: 10.1002/acm2.12237. Epub 2017 Dec 7. J Appl Clin Med Phys. 2018. PMID: 29218841 Free PMC article.
-
Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):188-94. doi: 10.1016/j.ijrobp.2013.04.048. Int J Radiat Oncol Biol Phys. 2013. PMID: 23920395
-
Volumetric modulated arc planning for lung stereotactic body radiotherapy using conventional and unflattened photon beams: a dosimetric comparison with 3D technique.Radiat Oncol. 2011 Nov 9;6:152. doi: 10.1186/1748-717X-6-152. Radiat Oncol. 2011. PMID: 22070866 Free PMC article.
-
Protons versus photons for the treatment of chordoma.Cochrane Database Syst Rev. 2021 Jul 1;7(7):CD013224. doi: 10.1002/14651858.CD013224.pub2. Cochrane Database Syst Rev. 2021. PMID: 34196007 Free PMC article.
-
Proton Therapy in the Management of Hepatocellular Carcinoma.Cancers (Basel). 2022 Jun 12;14(12):2900. doi: 10.3390/cancers14122900. Cancers (Basel). 2022. PMID: 35740567 Free PMC article. Review.
Cited by
-
CT-Guided Fiducial Marker Implantation with Ultra-fine 25-Gauge Needle Prior to Proton Therapy for Liver Malignancies.Cardiovasc Intervent Radiol. 2024 Sep;47(9):1287-1293. doi: 10.1007/s00270-024-03808-8. Epub 2024 Aug 22. Cardiovasc Intervent Radiol. 2024. PMID: 39174792
-
Oncohepatology: Navigating liver injury in the era of modern cancer therapy.World J Hepatol. 2025 Jun 27;17(6):106932. doi: 10.4254/wjh.v17.i6.106932. World J Hepatol. 2025. PMID: 40606932 Free PMC article. Review.
-
Role of Proton Beam Therapy in Hepatic Oligometastasis: Review of Evidence.Acta Med Litu. 2025;32(1):36-51. doi: 10.15388/Amed.2025.32.1.25. Epub 2025 Feb 18. Acta Med Litu. 2025. PMID: 40641535 Free PMC article.
References
-
- NCCN (2022) NCCN clinical practice guidelines in oncology, https://www.nccn.org/professionals/physician_gls (2022, Accessed 15/04/2022)
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical